Zacks Investment Research
29 Jul 2026, 16:51 UTC · 3h ago
Do Options Traders Know Something About Chemours Stock We Don't?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jul 2026, 16:51 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The Oct. 16, 2026 $6.00 Call options for The Chemours Company (CC) are exhibiting some of the highest implied volatility in the equity options market. — High implied volatility indicates market expectation of a significant price swing, though the direction remains uncertain.
+0.30The Zacks Consensus Estimate for Chemours' current quarter has been revised downward from 51 cents to 49 cents per share. — A downward revision in earnings estimates generally signals weakening fundamental outlooks for the period.
-0.20The Chemours Company is currently rated as a Zacks Rank #1 (Strong Buy). — A top-tier analyst rank provides a positive bias for long-term investors, though it is offset by the recent estimate revision.
+0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is rated as a Zacks Rank #1 (Strong Buy), although high implied volatility suggests significant uncertainty.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
3h ago
